Skip to content

Contact +44 (0) 20 7060 7474 email us

Medical Devices

China Cardiovascular Devices Market Analysis & Forecasts to 2015

 

Publication Date April 2009
Publisher Globaldata
Product Type Report
Pages 190
ISBN Number not applicable
Product Code GDA00099

Price

£2,350.00
approximately: $3,502 | €2,578

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

This report is an essential source for in-depth information and data relating to the China cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices market in China.

Scope

  • The report provides cardiovascular devices market information broken down into detailed categories and segments in China.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the cardiovascular devices market in China.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Executive Summary
  • 4 Definitions of Markets Covered in the Report
    • 4.1 Cardiovascular Devices
    • 4.2 Cardiac Rhythm Management
      • 4.2.1 Pacemakers
      • 4.2.2 Implantable Cardioverter Defibrillator (ICD)
      • 4.2.3 Cardiovascular Pacing and ICD Leads
      • 4.2.4 Cardiac Resynchronization Therapy
    • 4.3 Cardiovascular monitoring and diagnostic devices
      • 4.3.1 ECG Monitoring Equipment
      • 4.3.2 ECG Stress Testing Systems
      • 4.3.3 Holter Monitoring Systems
      • 4.3.4 Event Monitoring Systems
    • 4.4 Cardiovascular prosthetic device
      • 4.4.1 Prosthetic heart valves
      • 4.4.2 Cardiac Valve Repair
      • 4.4.3 Cardiac assist devices
    • 4.5 Cardiovascular Surgery
      • 4.5.1 Beating Heart Systems
      • 4.5.2 Perfusion Systems
      • 4.5.3 Cardiac Ablation Devices
      • 4.5.4 Cardiopulmonary Bypass Equipment
      • 4.5.5 Perfusion Disposables
    • 4.6 Electrophysiology
      • 4.6.1 Electrophysiology diagnostic catheter
      • 4.6.2 Electrophysiology ablation catheter
      • 4.6.3 Electrophysiology lab systems
    • 4.7 Interventional cardiology
      • 4.7.1 Coronary Stents
      • 4.7.2 Cardiac Catheters
      • 4.7.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters
      • 4.7.4 Coronary Guidewire
      • 4.7.5 Arteriotomy Closure Devices
    • 4.8 Peripheral vascular devices
      • 4.8.1 Peripheral Vascular Stents
      • 4.8.2 Inferior Vena Cava Filter
      • 4.8.3 PTA Balloon
      • 4.8.4 Aortic Stent Graft
      • 4.8.5 Embolic Protection Device
      • 4.8.6 Synthetic Surgical Grafts
      • 4.8.7 Peripheral Guidewire
  • 5 Healthcare Sector Review
    • 5.1 Healthcare Expenditure
    • 5.2 Healthcare Infrastructure
      • 5.2.1 Healthcare Personnel Data
      • 5.2.2 Healthcare Facilities Data
    • 5.3 Healthcare Policy
  • 6 Regulation System
    • 6.1 Medical Equipment Approval Process
      • 6.1.1 Classification
      • 6.1.2 Registration and Conformity assessment
      • 6.1.3 China Compulsory Certificate (CCC Mark)
      • 6.1.4 Labeling and Packaging
      • 6.1.5 Registration Fee
      • 6.1.6 Registration Period
    • 6.2 Post Market Surveillance (PMS)
  • 7 Pricing and Reimbursement
  • 8 Distribution Structure
  • 9 Cardiovascular Devices In China
    • 9.1 Cardiovascular Devices, China, Overall Revenue ($ mn), 2000-2015
    • 9.2 Cardiovascular Devices, China, Overall Volume (Units), 2000-2015
    • 9.3 Cardiovascular Devices, China, Cross Category Analysis, 2000-2015
    • 9.4 Cardiovascular Devices, China, Company Share (2006-2007)
  • 10 Cardiac Rhythm Management In China
    • 10.1 Cardiac Rhythm Management Overall Revenue (2000-2015)
      • 10.1.1 Cardiac Resynchronisation Therapy Overall Revenue (2000-2015)
      • 10.1.2 Implantable Cardioverter Defibrillator Overall Revenue (2000-2015)
      • 10.1.3 Pacemaker Overall Revenue (2000-2015)
    • 10.2 Cardiac Rhythm Management Overall Volume (2000-2015)
    • 10.3 Cardiac Rhythm Management, China, Cross Segment Analysis, 2000-2015
    • 10.4 Cardiac Rhythm Management Average Price (2000-2015)
    • 10.5 Cardiac Rhythm Management Market Dynamics
      • 10.5.1 Market Drivers
      • 10.5.2 Market Restraints
    • 10.6 Cardiac Rhythm Management Distribution Share (2007-2008)
    • 10.7 Cardiac Rhythm Management, China, Company Share (2006-2007)
    • 10.8 Cardiac Rhythm Management Future Outlook
  • 11 Cardiovascular Monitoring and Diagnostic Devices In China
    • 11.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015)
    • 11.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
    • 11.3 Cardiovascular Monitoring and Diagnostic Devices, China, Cross Segment Analysis, 2000-2015
    • 11.4 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015)
    • 11.5 Cardiovascular Monitoring & Diagnostic Devices Market Dynamics
      • 11.5.1 Market Drivers
      • 11.5.2 Market Restraints
    • 11.6 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008)
    • 11.7 Cardiovascular Monitoring and Diagnostic Devices, China, Company Share (2006-2007)
    • 11.8 Cardiovascular Monitoring and Diagnostic Devices Future Outlook
  • 12 Cardiovascular Prosthetic Devices In China
    • 12.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015)
      • 12.1.1 Cardiac Assist Devices Overall Revenue (2000-2015)
      • 12.1.2 Prosthetic Heart Valve Overall Revenue (2000-2015)
    • 12.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2015)
    • 12.3 Cardiovascular Prosthetic Devices, China, Cross Segment Analysis, 2000-2015
    • 12.4 Cardiovascular Prosthetic Devices Average Price (2000-2015)
    • 12.5 Cardiovascular Prosthetic Devices Market Dynamics
      • 12.5.1 Market Drivers
      • 12.5.2 Market Restraints
    • 12.6 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
    • 12.7 Cardiovascular Prosthetic Devices, China, Company Share (2006-2007)
    • 12.8 Cardiovascular Prosthetic Devices Future Outlook
  • 13 Cardiovascular Surgery In China
    • 13.1 Cardiovascular Surgery Overall Revenue (2000-2015)
    • 13.2 Cardiovascular Surgery Overall Volume (2000-2015)
    • 13.3 Cardiovascular Surgery, China, Cross Segment Analysis, 2000-2015
    • 13.4 Cardiovascular Surgery Average Price (2000-2015)
    • 13.5 Cardiovascular Surgery Market Dynamics
      • 13.5.1 Market Drivers
      • 13.5.2 Market Restraints
    • 13.6 Cardiovascular Surgery Distribution Share (2007-2008)
    • 13.7 Cardiovascular Surgery, China, Company Share (2006-2007)
    • 13.8 Cardiovascular Surgery Future Outlook
  • 14 Electrophysiology In China
    • 14.1 Electrophysiology Overall Revenue (2000-2015)
    • 14.2 Electrophysiology Overall Volume (2000-2015)
    • 14.3 Electrophysiology, China, Cross Segment Analysis, 2000-2015
    • 14.4 Electrophysiology Average Price (2000-2015)
    • 14.5 Electrophysiology Market Dynamics
      • 14.5.1 Market Drivers
      • 14.5.2 Market Restraints
    • 14.6 Electrophysiology Distribution Share (2007-2008)
    • 14.7 Electrophysiology, China, Company Share (2006-2007)
    • 14.8 Electrophysiology Future Outlook
  • 15 Interventional Cardiology In China
    • 15.1 Interventional Cardiology Overall Revenue (2000-2015)
      • 15.1.1 Cardiac Catheter Overall Revenue (2000-2015)
      • 15.1.2 Coronary Stent Overall Revenue (2000-2015)
      • 15.1.3 PTCA Balloon Overall Revenue (2000-2015)
    • 15.2 Interventional Cardiology Overall Volume (2000-2015)
    • 15.3 Interventional Cardiology, China, Cross Segment Analysis, 2000-2015
    • 15.4 Interventional Cardiology Average Price (2000-2015)
    • 15.5 Interventional Cardiology Market Dynamics
      • 15.5.1 Market Drivers
      • 15.5.2 Market Restraints
    • 15.6 Interventional Cardiology Distribution Share (2007-2008)
    • 15.7 Interventional Cardiology, China, Company Share (2006-2007)
    • 15.8 Interventional Cardiology Future Outlook
  • 16 Peripheral Vascular Devices In China
    • 16.1 Peripheral Vascular Devices Overall Revenue (2000-2015)
    • 16.2 Peripheral Vascular Devices Overall Volume (2000-2015)
    • 16.3 Peripheral Vascular Devices, China, Cross Segment Analysis, 2000-2015
    • 16.4 Peripheral Vascular Devices Average Price (2000-2015)
    • 16.5 Peripheral Vascular Devices Market Dynamics
      • 16.5.1 Market Drivers
      • 16.5.2 Market Restraints
    • 16.6 Peripheral Vascular Devices Distribution Share (2007-2008)
    • 16.7 Peripheral Vascular Devices, China, Company Share (2006-2007)
    • 16.8 Peripheral Vascular Devices Future Outlook
  • 17 Overview of Key Companies in China Cardiovascular Devices Market
    • 17.1 Boston Scientific Corporation Company Profile
      • 17.1.1 Company Overview
      • 17.1.2 Value Chain Analysis
      • 17.1.3 Boston Scientific Corporation Pipeline Products
    • 17.2 Cordis Corporation Company Profile
      • 17.2.1 Company Overview
      • 17.2.2 Cordis Corporation Pipeline Products
    • 17.3 Abbott Laboratories Company Profile
      • 17.3.1 Company Overview
      • 17.3.2 Value Chain Analysis
      • 17.3.3 Abbott Laboratories Pipeline Products
    • 17.4 Medtronic, Inc. Company Profile
      • 17.4.1 Company Overview
      • 17.4.2 Value Chain Analysis
      • 17.4.3 Medtronic, Inc. Pipeline Products
    • 17.5 BIOTRONIK GmbH & Co. KG Company Profile
      • 17.5.1 Company Overview
      • 17.5.2 BIOTRONIK GmbH & Co. KG Pipeline Products
    • 17.6 Terumo Corporation Company Profile
      • 17.6.1 Company Overview
      • 17.6.2 Value Chain Analysis
      • 17.6.3 Terumo Corporation Pipeline Products
    • 17.7 CMICS Medical Instrument Co., Ltd. Company Profile
      • 17.7.1 Company Overview
    • 17.8 Edan Instruments, Inc. Company Profile
      • 17.8.1 Company Overview
    • 17.9 Shenzhen Biocare Electronics Co., Ltd. Company Profile
      • 17.9.1 Company Overview
  • 18 Financial Deals Landscape
    • 18.1 Acquisition
      • 18.1.1 Biosensors International Group Acquires 50% Interest In JW Medical Systems
    • 18.2 Partnerships
      • 18.2.1 ev3 Enters Into Distribution Agreement With Lepu
  • 19 Recent Developments
    • 19.1 Strategy and Business Planning
      • 19.1.1 Jul 28, 2008: Mingyuan Enters Strategic Co-Operation Memorandum with GE (CHINA)
      • 19.1.2 Dec 17, 2007: Medtronic and Weigao Announce Joint Venture in China
      • 19.1.3 Jul 18, 2006: CardioDynamics Signs Contract with Mindray
    • 19.2 Product News
      • 19.2.1 Nov 07, 2008: Interim Analysis of Data From e-HEALING Registry of OrbusNeich's Genous Bio-Engineered R Stent to Be Presented At AHA Scientific Sessions 2008
      • 19.2.2 Oct 14, 2008: Interim Analysis Of 12-Month Data From e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich's Genous Bio-engineered R stent
      • 19.2.3 Aug 05, 2008: Major Health Organizations In China Install ZOLL Defbrillators
    • 19.3 Other Significant Developments
      • 19.3.1 Jul 01, 2008: GE Healthcare to Aid Early Diagnosis of All Competing Olympic Athletes at the Beijing 2008 Olympic Games
      • 19.3.2 May 16, 2008: Abbott Contributes To Disaster Relief Efforts In China And Myanmar
      • 19.3.3 Jun 18, 2007: IBA Opens A New Asian Headquarter Office In Beijing
  • 20 Appendix
    • 20.1 GlobalData Research Methodology
    • 20.2 Coverage
    • 20.3 Secondary Research
    • 20.4 Primary Research
    • 20.5 Models
    • 20.6 Forecasts
    • 20.7 Expert Panel Validation
    • 20.8 Currency Conversion
    • 20.9 Contact Us
    • 20.10 Disclaimer
  • 1 List of Tables
    • Table 1: Doctors by Specialty in China, 2003-2007
    • Table 2: Hospital Wards by Specialty in China, 2003 - 2007
    • Table 3: Healthcare Institutions in China, 2000-2006
    • Table 4: Personnel Employed in Healthcare Institutions in China, 2000-2006
    • Table 5: Healthcare Institutions, Hospital Beds and Employed Personnel by Region in China, 2006
    • Table 6: Cardiovascular Devices, China, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 7: Cardiovascular Devices, China, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 8: Cardiovascular Devices, China, Overall Volume (Units), Historic, 2000-2008
    • Table 9: Cardiovascular Devices, China, Overall Volume (Units), Forecast, 2008-2015
    • Table 10: Cardiovascular Devices, China, Cross Category Analysis, 2000-2015
    • Table 11: Cardiovascular Devices, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 12: Cardiac Rhythm Management, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 13: Cardiac Rhythm Management, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 14: Cardiac Resynchronisation Therapy, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 15: Cardiac Resynchronisation Therapy, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 16: Implantable Cardioverter Defibrillator, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 17: Implantable Cardioverter Defibrillator, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 18: Pacemaker, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 19: Pacemaker, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 20: Cardiac Rhythm Management, China, Volume (Units) by Segment, Historic, 2000-2008
    • Table 21: Cardiac Rhythm Management, China, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 22: Cardiac Rhythm Management, China, Cross Segment Analysis, 2000-2015
    • Table 23: Cardiac Rhythm Management, China, Average Price ($), Historic, 2000-2008
    • Table 24: Cardiac Rhythm Management, China, Average Price ($), Forecast, 2008-2015
    • Table 25: Cardiac Rhythm Management, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 26: Cardiac Rhythm Management, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 27: Cardiovascular Monitoring and Diagnostic Devices, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 28: Cardiovascular Monitoring and Diagnostic Devices, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 29: Cardiovascular Monitoring and Diagnostic Devices, China, Volume (Units) by Segment, Historic, 2000-2008
    • Table 30: Cardiovascular Monitoring and Diagnostic Devices, China, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 31: Cardiovascular Monitoring and Diagnostic Devices, China, Cross Segment Analysis, 2000-2015
    • Table 32: Cardiovascular Monitoring and Diagnostic Devices, China, Average Price ($), Historic, 2000-2008
    • Table 33: Cardiovascular Monitoring and Diagnostic Devices, China, Average Price ($), Forecast, 2008-2015
    • Table 34: Cardiovascular Monitoring and Diagnostic Devices, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 35: Cardiovascular Monitoring and Diagnostic Devices, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 36: Cardiovascular Prosthetic Devices, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 37: Cardiovascular Prosthetic Devices, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 38: Cardiac Assist Devices, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 39: Cardiac Assist Devices, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 40: Prosthetic Heart Valve, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 41: Prosthetic Heart Valve, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 42: Cardiovascular Prosthetic Devices, China, Volume (Units) by Segment, Historic, 2000-2008
    • Table 43: Cardiovascular Prosthetic Devices, China, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 44: Cardiovascular Prosthetic Devices, China, Cross Segment Analysis, 2000-2015
    • Table 45: Cardiovascular Prosthetic Devices, China, Average Price ($), Historic, 2000-2008
    • Table 46: Cardiovascular Prosthetic Devices, China, Average Price ($), Forecast, 2008-2015
    • Table 47: Cardiovascular Prosthetic Devices, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 48: Cardiovascular Prosthetic Devices, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 49: Cardiovascular Surgery, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 50: Cardiovascular Surgery, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 51: Cardiovascular Surgery, China, Volume (Units) by Segment, Historic, 2000-2008
    • Table 52: Cardiovascular Surgery, China, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 53: Cardiovascular Surgery, China, Cross Segment Analysis, 2000-2015
    • Table 54: Cardiovascular Surgery, China, Average Price ($), Historic, 2000-2008
    • Table 55: Cardiovascular Surgery, China, Average Price ($), Forecast, 2008-2015
    • Table 56: Cardiovascular Surgery, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 57: Cardiovascular Surgery, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 58: Electrophysiology, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 59: Electrophysiology, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 60: Electrophysiology, China, Volume (Units) by Segment, Historic, 2000-2008
    • Table 61: Electrophysiology, China, Volume (Units), Forecast, 2008-2015
    • Table 62: Electrophysiology, China, Cross Segment Analysis, 2000-2015
    • Table 63: Electrophysiology, China, Average Price ($), Historic, 2000-2008
    • Table 64: Electrophysiology, China, Average Price ($), Forecast, 2008-2015
    • Table 65: Electrophysiology, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 66: Electrophysiology, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 67: Interventional Cardiology, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 68: Interventional Cardiology, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 69: Cardiac Catheter, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 70: Cardiac Catheter, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 71: Coronary Stent, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 72: Coronary Stent, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 73: PTCA Balloon, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 74: PTCA Balloon, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 75: Interventional Cardiology, China, Volume (Units) by Segment, Historic, 2000-2008
    • Table 76: Interventional Cardiology, China, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 77: Interventional Cardiology, China, Cross Segment Analysis, 2000-2015
    • Table 78: Interventional Cardiology, China, Average Price ($), Historic, 2000-2008
    • Table 79: Interventional Cardiology, China, Average Price ($), Forecast, 2008-2015
    • Table 80: Interventional Cardiology, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 81: Interventional Cardiology, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 82: Peripheral Vascular Devices, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 83: Peripheral Vascular Devices, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 84: Peripheral Vascular Devices, China, Volume (Units) by Segment, Historic, 2000-2008
    • Table 85: Peripheral Vascular Devices, China, Volume (Units) by Segment, Forecast, 2008-2015
    • Table 86: Peripheral Vascular Devices, China, Cross Segment Analysis, 2000-2015
    • Table 87: Peripheral Vascular Devices, China, Average Price ($), Historic, 2000-2008
    • Table 88: Peripheral Vascular Devices, China, Average Price ($), Forecast, 2008-2015
    • Table 89: Peripheral Vascular Devices, China, Distribution Share by Revenue ($mn), 2007-2008
    • Table 90: Peripheral Vascular Devices, China, Company Share by Revenue ($ mn), 2006-2007
    • Table 91: Boston Scientific Corporation Pipeline Products by Equipment Type
    • Table 92: Boston Scientific Corporation Pipeline Products By Development Stage
    • Table 93: Boston Scientific Corporation Pipeline Products By Therapy Area
    • Table 94: Boston Scientific Corporation Pipeline Products By Clinical Trials
    • Table 95: Boston Scientific Corporation Pipeline Products By News Summaries
    • Table 96: Cordis Corporation Pipeline Products by Equipment Type
    • Table 97: Cordis Corporation Pipeline Products by Development Stage
    • Table 98: Cordis Corporation Pipeline Products by Therapy Area
    • Table 99: Cordis Corporation Pipeline Products by Clinical Trials
    • Table 100: Cordis Corporation Pipeline Products by News Summaries
    • Table 101: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 102: Abbott Laboratories Pipeline Products by Development Stage
    • Table 103: Abbott Laboratories Pipeline Products by Therapy Area
    • Table 104: Abbott Laboratories Pipeline Products by Clinical Trials
    • Table 105: Abbott Laboratories Pipeline Products by News Summaries
    • Table 106: Medtronic, Inc. Pipeline Products by Equipment Type
    • Table 107: Medtronic, Inc. Pipeline Products by Development Stage
    • Table 108: Medtronic, Inc. Pipeline Products by Therapy Area
    • Table 109: Medtronic, Inc. Pipeline Products by Clinical Trials
    • Table 110: Medtronic, Inc. Pipeline Products by News Summaries
    • Table 111: BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type
    • Table 112: BIOTRONIK GmbH & Co. KG Pipeline Products by Development Stage
    • Table 113: BIOTRONIK GmbH & Co. KG Pipeline Products by Therapy Area
    • Table 114: BIOTRONIK GmbH & Co. KG Pipeline Products by Clinical Trials
    • Table 115: BIOTRONIK GmbH & Co. KG Pipeline Products by News Summaries
    • Table 116: Terumo Corporation Pipeline Products by Equipment Type
    • Table 117: Terumo Corporation Pipeline Products By Development Stage
    • Table 118: Terumo Corporation Pipeline Products By Therapy Area
    • Table 119: Terumo Corporation Pipeline Products By Clinical Trials
    • Table 120: Terumo Corporation Pipeline Products By News Summaries
    • Table 121: Biosensors International Group Acquires 50% Interest In JW Medical Systems
    • Table 122: ev3 Enters Into Distribution Agreement With Lepu
    • Table 123: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in China, 2000 - 2005
    • Figure 2: Medical Equipment Registration Process in China, 2007
    • Figure 3: CCC Mark Certification Process in China, 2007
    • Figure 4: Cardiovascular Devices, China, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 5: Cardiovascular Devices, China, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 6: Cardiovascular Devices, China, Cross Category Analysis, 2000-2015
    • Figure 7: Cardiovascular Devices, China, Company Share (%), 2007
    • Figure 8: Cardiac Rhythm Management, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 9: Cardiac Rhythm Management, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 10: Cardiac Resynchronisation Therapy, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 11: Cardiac Resynchronisation Therapy, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 12: Implantable Cardioverter Defibrillator, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 13: Implantable Cardioverter Defibrillator, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 14: Pacemaker, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 15: Pacemaker, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 16: Cardiac Rhythm Management, China, Cross Segment Analysis, 2000-2015
    • Figure 17: Cardiac Rhythm Management, China, Company Share (%), 2007
    • Figure 18: Cardiovascular Monitoring and Diagnostic Devices, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 19: Cardiovascular Monitoring and Diagnostic Devices, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 20: Cardiovascular Monitoring and Diagnostic Devices, China, Cross Segment Analysis, 2000-2015
    • Figure 21: Cardiovascular Monitoring and Diagnostic Devices, China, Company Share (%), 2007
    • Figure 22: Cardiovascular Prosthetic Devices, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 23: Cardiovascular Prosthetic Devices, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 24: Cardiac Assist Devices, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 25: Cardiac Assist Devices, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 26: Prosthetic Heart Valve, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 27: Prosthetic Heart Valve, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 28: Cardiovascular Prosthetic Devices, China, Cross Segment Analysis, 2000-2015
    • Figure 29: Cardiovascular Prosthetic Devices, China, Company Share (%), 2007
    • Figure 30: Cardiovascular Surgery, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 31: Cardiovascular Surgery, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 32: Cardiovascular Surgery, China, Cross Segment Analysis, 2000-2015
    • Figure 33: Cardiovascular Surgery, China, Company Share (%), 2007
    • Figure 34: Electrophysiology, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 35: Electrophysiology, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 36: Electrophysiology, China, Cross Segment Analysis, 2000-2015
    • Figure 37: Electrophysiology, China, Company Share (%), 2007
    • Figure 38: Interventional Cardiology, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 39: Interventional Cardiology, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 40: Cardiac Catheter, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 41: Cardiac Catheter, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 42: Coronary Stent, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 43: Coronary Stent, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 44: PTCA Balloon, China, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 45: PTCA Balloon, China, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 46: Interventional Cardiology, China, Cross Segment Analysis, 2000-2015
    • Figure 47: Interventional Cardiology, China, Company Share (%), 2007
    • Figure 48: Peripheral Vascular Devices, China, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 49: Peripheral Vascular Devices, China, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 50: Peripheral Vascular Devices, China, Volume (Units) by Segment, Historic, 2000-2008
    • Figure 51: Peripheral Vascular Devices, China, Volume (Units) by Segment, Forecast, 2008-2015
    • Figure 52: Peripheral Vascular Devices, China, Cross Segment Analysis, 2000-2015
    • Figure 53: Peripheral Vascular Devices, China, Company Share (%), 2007
    • Figure 54: Boston Scientific Corporation Value Chain Analysis
    • Figure 55: Abbott Laboratories Value Chain Analysis
    • Figure 56: Medtronic, Inc., Value Chain Analysis
    • Figure 57: Terumo Corporation Value Chain Analysis
    • Figure 58: GlobalData Methodology